Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours. The cells that form gestational trophoblastic tumours are called trophoblasts and come from tissue that grows to form the placenta during pregnancy.
Gestational trophoblastic disease (GTD) includes hydatidiform moles, benign lesions, and gestational trophoblastic neoplasms. Complete and partial hydatidiform moles are abnormal pregnancies characterized by placental abnormalities. Diagnosis involves clinical assessment, histopathology, and tumor marker testing. Treatment ranges from surgical evacuation to multi-agent chemotherapy depending on disease extent and prognosis. Long-term follow up is important due to risk of persistent or recurrent GTD. Gestational trophoblastic neoplasia can develop after molar or non-molar pregnancies and may metastasize, requiring more intensive treatment. Precise classification, staging, and risk stratification guide personalized management of GTD
Endometrial polyps are benign growths that occur in the endometrium. They are common in women over 40 and can cause abnormal bleeding. On pathology, they appear as irregular glandular growths with thick-walled blood vessels and fibrotic stroma. While most are non-cancerous, polyps are associated with a slightly increased risk of endometrial cancer and need to be evaluated. Treatment involves surgical removal, such as with a hysteroscopic polypectomy.
Gestational trophoblastic disease (GTD) is a heterogeneous group of lesions characterized by abnormal trophoblast proliferation. GTD includes complete and partial hydatidiform moles, which are abnormally formed placentas with genetic abnormalities, as well as choriocarcinoma and placental site trophoblastic tumor, which are true neoplasms of previllous and extravillous trophoblast, respectively. Complete moles have a diploid karyotype composed entirely of paternal chromosomes and produce marked uterine enlargement without a fetus. Partial moles have a triploid karyotype and may contain a malformed fetus. Choriocarcinoma is a malignant neoplasm composed of trophoblast without villi
This document discusses miscarriage and related topics in obstetrics and gynecology. It defines different types of miscarriage such as threatened, inevitable, incomplete, and missed/silent miscarriage. It covers etiologies, risk factors, clinical presentations, investigations and management approaches for miscarriage. Key points include that 50% of spontaneous miscarriages are due to chromosomal abnormalities, infection is an unclear cause of recurrent miscarriage, and management involves either conservative expectant monitoring or surgical evacuation of retained products of conception.
The document discusses gestational trophoblastic diseases including hydatidiform mole, invasive mole, choriocarcinoma, and placental-site trophoblastic tumor. It covers the pathology, diagnosis, clinical findings, differential diagnosis, treatment, and classification of malignant gestational trophoblastic neoplasia for each condition. Key points include that these diseases are derived from fetal tissue, features of complete versus partial hydatidiform mole on pathology and hCG levels, chemotherapy regimens used for treating metastatic or high risk nonmetastatic disease, and hysterectomy as a treatment for placental-site trophoblastic tumor.
The document discusses adenomyosis, a benign condition where endometrial tissue grows within the uterine wall. It defines adenomyosis and describes associated symptoms like pelvic pain and abnormal bleeding. Diagnosis can only be confirmed by pathology after hysterectomy, though other imaging methods like ultrasound and MRI can provide clues. TVUS shows heterogeneous myometrial texture while MRI may detect increased thickness or consistency changes in the myometrium.
Prolonged pregnancy refers to gestation lasting 42 weeks or more. The cause is still unknown, but it may be related to changes in the fetal brain that initiate labor or a placental estrogen deficiency. As pregnancy progresses past 40 weeks, amniotic fluid levels decrease from 500-1000 ml to around 400 ml by 42-43 weeks. This decrease in amniotic fluid can lead to compression of the umbilical cord and reduced blood flow to the fetus, resulting in potential complications like meconium aspiration, hypoglycemia, or polycythemia in the fetus. If left untreated, this condition known as dysmaturity syndrome can occur in 1-2% of postmature fetuses and cause skin changes,
Fibroids are the most common benign tumors of the female reproductive system. They arise from the smooth muscle cells of the uterus and affect 20-40% of women of reproductive age. The exact cause is unknown but risk factors include age, family history, obesity, and black race. Symptoms include heavy menstrual bleeding, pain, and a pelvic mass. Diagnosis is usually made clinically or with ultrasound. Treatment depends on symptoms and desire for future fertility, and may include medication, surgery such as myomectomy or hysterectomy, uterine artery embolization, or watchful waiting.
Gestational trophoblastic disease (GTD) includes hydatidiform moles, benign lesions, and gestational trophoblastic neoplasms. Complete and partial hydatidiform moles are abnormal pregnancies characterized by placental abnormalities. Diagnosis involves clinical assessment, histopathology, and tumor marker testing. Treatment ranges from surgical evacuation to multi-agent chemotherapy depending on disease extent and prognosis. Long-term follow up is important due to risk of persistent or recurrent GTD. Gestational trophoblastic neoplasia can develop after molar or non-molar pregnancies and may metastasize, requiring more intensive treatment. Precise classification, staging, and risk stratification guide personalized management of GTD
Endometrial polyps are benign growths that occur in the endometrium. They are common in women over 40 and can cause abnormal bleeding. On pathology, they appear as irregular glandular growths with thick-walled blood vessels and fibrotic stroma. While most are non-cancerous, polyps are associated with a slightly increased risk of endometrial cancer and need to be evaluated. Treatment involves surgical removal, such as with a hysteroscopic polypectomy.
Gestational trophoblastic disease (GTD) is a heterogeneous group of lesions characterized by abnormal trophoblast proliferation. GTD includes complete and partial hydatidiform moles, which are abnormally formed placentas with genetic abnormalities, as well as choriocarcinoma and placental site trophoblastic tumor, which are true neoplasms of previllous and extravillous trophoblast, respectively. Complete moles have a diploid karyotype composed entirely of paternal chromosomes and produce marked uterine enlargement without a fetus. Partial moles have a triploid karyotype and may contain a malformed fetus. Choriocarcinoma is a malignant neoplasm composed of trophoblast without villi
This document discusses miscarriage and related topics in obstetrics and gynecology. It defines different types of miscarriage such as threatened, inevitable, incomplete, and missed/silent miscarriage. It covers etiologies, risk factors, clinical presentations, investigations and management approaches for miscarriage. Key points include that 50% of spontaneous miscarriages are due to chromosomal abnormalities, infection is an unclear cause of recurrent miscarriage, and management involves either conservative expectant monitoring or surgical evacuation of retained products of conception.
The document discusses gestational trophoblastic diseases including hydatidiform mole, invasive mole, choriocarcinoma, and placental-site trophoblastic tumor. It covers the pathology, diagnosis, clinical findings, differential diagnosis, treatment, and classification of malignant gestational trophoblastic neoplasia for each condition. Key points include that these diseases are derived from fetal tissue, features of complete versus partial hydatidiform mole on pathology and hCG levels, chemotherapy regimens used for treating metastatic or high risk nonmetastatic disease, and hysterectomy as a treatment for placental-site trophoblastic tumor.
The document discusses adenomyosis, a benign condition where endometrial tissue grows within the uterine wall. It defines adenomyosis and describes associated symptoms like pelvic pain and abnormal bleeding. Diagnosis can only be confirmed by pathology after hysterectomy, though other imaging methods like ultrasound and MRI can provide clues. TVUS shows heterogeneous myometrial texture while MRI may detect increased thickness or consistency changes in the myometrium.
Prolonged pregnancy refers to gestation lasting 42 weeks or more. The cause is still unknown, but it may be related to changes in the fetal brain that initiate labor or a placental estrogen deficiency. As pregnancy progresses past 40 weeks, amniotic fluid levels decrease from 500-1000 ml to around 400 ml by 42-43 weeks. This decrease in amniotic fluid can lead to compression of the umbilical cord and reduced blood flow to the fetus, resulting in potential complications like meconium aspiration, hypoglycemia, or polycythemia in the fetus. If left untreated, this condition known as dysmaturity syndrome can occur in 1-2% of postmature fetuses and cause skin changes,
Fibroids are the most common benign tumors of the female reproductive system. They arise from the smooth muscle cells of the uterus and affect 20-40% of women of reproductive age. The exact cause is unknown but risk factors include age, family history, obesity, and black race. Symptoms include heavy menstrual bleeding, pain, and a pelvic mass. Diagnosis is usually made clinically or with ultrasound. Treatment depends on symptoms and desire for future fertility, and may include medication, surgery such as myomectomy or hysterectomy, uterine artery embolization, or watchful waiting.
This document discusses endometriosis, including its definition, theories of pathogenesis, risk factors, clinical presentation, investigations, staging, and management approaches. It provides an overview of endometriosis, describing it as the presence of functioning endometrial tissue outside the uterine cavity, with a reported incidence of 20-25% in the reproductive age group. Theories discussed to explain its pathogenesis include retrograde menstruation, coelomic metaplasia, and metastasis. Hormonal factors, immunology, and genetics are also implicated in its development. Staging is typically done using the revised American Fertility Society classification system. Management involves a tailored approach considering symptoms, fertility goals, and side effects of treatments.
Gestational trophoblastic neoplasia (GTN) is a spectrum of diseases caused by abnormal proliferation of trophoblastic tissue. It includes complete and partial hydatidiform moles, invasive moles, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. Choriocarcinoma is a malignant form that can develop from any type of pregnancy and has a high risk of metastasis. Diagnosis involves elevated hCG levels, imaging, and histopathology. Treatment depends on the type and severity but may include suction dilation and curettage, chemotherapy, and radiation therapy.
The document discusses oligohydramnios, which is defined as a low volume of amniotic fluid. It describes the normal physiology of amniotic fluid, including inflow from fetal urine and swallowing and outflow from the lungs and membranes. Causes of oligohydramnios include premature rupture of membranes, fetal abnormalities, restricted growth, and maternal conditions like preeclampsia. Ultrasound is used to diagnose oligohydramnios by measuring the amniotic fluid index or single deepest pocket. Management depends on the etiology and gestational age but may include increased fluid intake, monitoring, induction of labor, or amnioinfusion during labor.
1) Adenomyosis is characterized by ectopic endometrial tissue within the myometrium and prevalence increases with age and multiparity.
2) It can contribute to infertility by impairing sperm transport and destruction of the myometrial architecture.
3) MRI is more specific than transvaginal ultrasound in diagnosing adenomyosis based on junctional zone thickness measurements.
4) Prolonged GnRH agonist treatment prior to IVF was found to minimize any adverse effects of adenomyosis on implantation and pregnancy rates.
5) The LNG-IUS and UAE show promise in effectively treating adenomyosis symptoms like heavy bleeding and pain.
Molar pregnancy is a premalignant condition that occurs after abnormal fertilization and is characterized by swollen chorionic villi. There are two types: complete and partial hydatidiform moles. Complete moles have no fetal tissue and are diploid, while partial moles may contain nonviable fetal tissue and are usually triploid. Symptoms include vaginal bleeding, uterine enlargement, and hyperemesis gravidarum. Complications can include hemorrhage, sepsis, invasive mole, and choriocarcinoma. Diagnosis is made through hCG levels, ultrasound showing cystic spaces without fetal parts, and pathology. Treatment is suction curettage, with follow up hCG monitoring to
Rh isoimmunization occurs when an Rh-negative mother carries an Rh-positive fetus. During pregnancy or delivery, fetal red blood cells can enter the mother's circulation, stimulating her immune system to produce antibodies against the Rh antigen. These antibodies can then cross the placenta during subsequent pregnancies and destroy fetal red blood cells, causing hemolytic disease of the newborn. Effects range from mild anemia to severe jaundice, hydrops fetalis, or fetal death. Management involves monitoring maternal antibody levels and fetal well-being through amniocentesis and ultrasound. At-risk pregnancies may require intrauterine transfusions or early delivery. Prevention relies on administering Rh immunoglobulin to the mother during
Invasive mole is a complication of molar pregnancy where abnormal villi grow into the myometrium or blood vessels. It occurs in approximately 15% of complete moles and can metastasize to other organs. Clinical features include persistent hemorrhage and uterine perforation. Microscopically, proliferating trophoblast tissue is seen invading the myometrium. Treatment involves chemotherapy, with single or combination drug regimens depending on the disease stage. The goals are to normalize hCG levels and administer additional "clean-up" courses of chemotherapy.
Adenomyosis is a benign condition where endometrial tissue grows into the myometrium. It causes the uterus to enlarge asymmetrically, especially on the posterior wall. Women with adenomyosis typically experience heavy menstrual bleeding and painful periods that can occur throughout the month. Ultrasound and MRI can detect adenomyosis by showing cysts in the thickened myometrium and an indistinct endomyometrial junction. Treatment depends on a woman's age and fertility desires, ranging from medication like NSAIDs and oral contraceptives to hysterectomy for older, parous women.
An ectopic pregnancy occurs when a fertilized egg implants outside of the uterus, usually in the fallopian tubes. Risk factors include previous ectopic pregnancy, infections, scarring of the fallopian tubes, and fertility treatments. Ectopic pregnancies can cause life-threatening bleeding if not treated properly. Diagnosis involves beta-hCG levels and ultrasound imaging. Treatment options include medication with methotrexate, expectant management with close monitoring, or surgery depending on the stability of the patient and characteristics of the ectopic pregnancy.
A molar pregnancy occurs when abnormal placental tissue develops instead of a fetus. There are two types: complete and partial moles. A complete mole shows trophoblastic proliferation throughout the placenta and no fetal tissue, while a partial mole shows slight, focal proliferation and may contain some fetal tissue. Clinical features can include vaginal bleeding, uterine enlargement beyond dates, and very high hCG levels in the case of a complete mole. Diagnosis is made through histopathological examination of tissue.
1. Thyroid function changes during pregnancy due to increases in thyroid binding globulin, human chorionic gonadotropin, and other factors. This can cause hyperthyroidism or hypothyroidism.
2. Hyperthyroidism occurs in 0.2% of pregnancies, often due to Graves' disease. It increases risk of complications. Hypothyroidism occurs in 2-3% and also increases risks if not treated.
3. Postpartum thyroiditis involves transient hyperthyroidism and/or hypothyroidism after delivery. Long term hypothyroidism can occur. Thyroid cancer diagnosis and treatment requires consideration of pregnancy.
1. Ectopic pregnancy occurs when a fertilized egg implants outside of the uterus, most commonly in one of the fallopian tubes. It has become more common in recent decades due to rising rates of pelvic inflammatory disease, infertility treatments, and intrauterine device use.
2. Ectopic pregnancies are usually diagnosed through clinical history and examination combined with serum human chorionic gonadotropin (hCG) levels and transvaginal ultrasound. hCG levels that are rising slower than normal or an ultrasound that shows an empty uterus with a pregnancy sac located elsewhere can indicate an ectopic pregnancy.
3. Treatment depends on the individual case but typically involves surgery to remove the ectopic pregnancy
- Fibroids are benign smooth muscle tumors that arise from the uterus. They are very common, affecting 20-30% of women.
- Symptoms include heavy menstrual bleeding, pelvic pressure, pain, and infertility. Fibroids can range in size from small to very large masses.
- Diagnosis is usually made through ultrasound imaging. Surgical treatment options include myomectomy to remove fibroids or hysterectomy for multiple or large fibroids. Conservative management is also an option for small asymptomatic fibroids.
gyanaecology.endometriosis and adenomyosis.(dr.salama)student
The document summarizes endometriosis and adenomyosis. Endometriosis occurs when endometrial tissue grows outside the uterus, most commonly on the ovaries, uterine ligaments and pelvis. It causes pain and infertility. Adenomyosis involves endometrial tissue in the uterine wall. Both can be diagnosed by laparoscopy and treated through drugs or surgery, with hysterectomy providing definitive treatment for severe adenomyosis.
The three main categories of early pregnancy disorders are abortion, ectopic pregnancy, and gestational trophoblastic disease. Abortion can be threatened, inevitable, incomplete, complete, or missed depending on whether fetal and placental tissues have been expelled. Ectopic pregnancies occur outside the uterus, often in the fallopian tubes, and can cause pain and bleeding. Gestational trophoblastic disease includes complete and partial hydatidiform moles, as well as choriocarcinoma, and involves abnormal proliferation of trophoblast tissue.
Multiple pregnancies are associated with increased risks for both the mother and fetuses. Maternal risks include preeclampsia, anemia, preterm labor, and postpartum hemorrhage. Fetal risks are also increased and include low birth weight, prematurity, intrauterine growth restriction, congenital anomalies, and twin-twin transfusion syndrome in monochorionic twins. Careful antenatal monitoring and management can help prolong gestation and improve outcomes.
Gestational trophoblastic disease is a heterogeneous group of lesions arising from abnormal placental trophoblast proliferation. It includes premalignant conditions like complete and partial hydatidiform moles, as well as malignant gestational trophoblastic neoplasia (GTN). GTN has varying potential for local invasion and metastasis. While rare, GTN is highly curable even with widespread dissemination. Treatment involves chemotherapy, with single or multi-agent regimens depending on risk factors and disease stage according to the FIGO scoring system. Careful monitoring of beta-hCG levels is important for diagnosis and follow-up.
This document provides information about Caesarean section (C-section), including its definition, indications, types, and procedures. Some key points:
- A C-section is a surgical procedure to deliver babies through incisions in the abdominal and uterine walls after 28 weeks of pregnancy. Its use has steadily increased to around 25% currently due to various medical and safety factors.
- Indications can be maternal, fetal, or both and include conditions like cephalopelvic disproportion, breech presentation, fetal distress, and previous C-section.
- The two main types are lower segment (transverse incision below the bladder) and upper segment (vertical incision through the upper uterus), with
Seminar on gestational trophoblastic disease (gtd) (f inal)Santosh Narayankar
The document discusses gestational trophoblastic disease, specifically hydatidiform mole and choriocarcinoma. It covers the types, causes, risk factors, signs and symptoms, diagnostic methods, treatment options and follow up protocols for these conditions. Hydatidiform mole is characterized by abnormal proliferation of chorionic villi and can be complete or partial. Choriocarcinoma is a highly malignant form that may metastasize and behaves like a carcinoma or sarcoma.
Gestational Trophoblastic Disease By Prof. Dr. Rafia Balochrafiabaloch
This document provides information on gestational trophoblastic disease (GTD), which includes complete and partial hydatidiform moles, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. It discusses the definitions, types, risk factors, pathogenesis, clinical presentation, diagnosis, treatment and management of GTD. Molar pregnancies are diagnosed using ultrasound imaging and quantitative beta-HCG levels. Treatment involves suction dilation and curettage followed by careful monitoring of beta-HCG levels to detect persistent trophoblastic disease. Chemotherapy may be used in high risk cases.
This document discusses endometriosis, including its definition, theories of pathogenesis, risk factors, clinical presentation, investigations, staging, and management approaches. It provides an overview of endometriosis, describing it as the presence of functioning endometrial tissue outside the uterine cavity, with a reported incidence of 20-25% in the reproductive age group. Theories discussed to explain its pathogenesis include retrograde menstruation, coelomic metaplasia, and metastasis. Hormonal factors, immunology, and genetics are also implicated in its development. Staging is typically done using the revised American Fertility Society classification system. Management involves a tailored approach considering symptoms, fertility goals, and side effects of treatments.
Gestational trophoblastic neoplasia (GTN) is a spectrum of diseases caused by abnormal proliferation of trophoblastic tissue. It includes complete and partial hydatidiform moles, invasive moles, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. Choriocarcinoma is a malignant form that can develop from any type of pregnancy and has a high risk of metastasis. Diagnosis involves elevated hCG levels, imaging, and histopathology. Treatment depends on the type and severity but may include suction dilation and curettage, chemotherapy, and radiation therapy.
The document discusses oligohydramnios, which is defined as a low volume of amniotic fluid. It describes the normal physiology of amniotic fluid, including inflow from fetal urine and swallowing and outflow from the lungs and membranes. Causes of oligohydramnios include premature rupture of membranes, fetal abnormalities, restricted growth, and maternal conditions like preeclampsia. Ultrasound is used to diagnose oligohydramnios by measuring the amniotic fluid index or single deepest pocket. Management depends on the etiology and gestational age but may include increased fluid intake, monitoring, induction of labor, or amnioinfusion during labor.
1) Adenomyosis is characterized by ectopic endometrial tissue within the myometrium and prevalence increases with age and multiparity.
2) It can contribute to infertility by impairing sperm transport and destruction of the myometrial architecture.
3) MRI is more specific than transvaginal ultrasound in diagnosing adenomyosis based on junctional zone thickness measurements.
4) Prolonged GnRH agonist treatment prior to IVF was found to minimize any adverse effects of adenomyosis on implantation and pregnancy rates.
5) The LNG-IUS and UAE show promise in effectively treating adenomyosis symptoms like heavy bleeding and pain.
Molar pregnancy is a premalignant condition that occurs after abnormal fertilization and is characterized by swollen chorionic villi. There are two types: complete and partial hydatidiform moles. Complete moles have no fetal tissue and are diploid, while partial moles may contain nonviable fetal tissue and are usually triploid. Symptoms include vaginal bleeding, uterine enlargement, and hyperemesis gravidarum. Complications can include hemorrhage, sepsis, invasive mole, and choriocarcinoma. Diagnosis is made through hCG levels, ultrasound showing cystic spaces without fetal parts, and pathology. Treatment is suction curettage, with follow up hCG monitoring to
Rh isoimmunization occurs when an Rh-negative mother carries an Rh-positive fetus. During pregnancy or delivery, fetal red blood cells can enter the mother's circulation, stimulating her immune system to produce antibodies against the Rh antigen. These antibodies can then cross the placenta during subsequent pregnancies and destroy fetal red blood cells, causing hemolytic disease of the newborn. Effects range from mild anemia to severe jaundice, hydrops fetalis, or fetal death. Management involves monitoring maternal antibody levels and fetal well-being through amniocentesis and ultrasound. At-risk pregnancies may require intrauterine transfusions or early delivery. Prevention relies on administering Rh immunoglobulin to the mother during
Invasive mole is a complication of molar pregnancy where abnormal villi grow into the myometrium or blood vessels. It occurs in approximately 15% of complete moles and can metastasize to other organs. Clinical features include persistent hemorrhage and uterine perforation. Microscopically, proliferating trophoblast tissue is seen invading the myometrium. Treatment involves chemotherapy, with single or combination drug regimens depending on the disease stage. The goals are to normalize hCG levels and administer additional "clean-up" courses of chemotherapy.
Adenomyosis is a benign condition where endometrial tissue grows into the myometrium. It causes the uterus to enlarge asymmetrically, especially on the posterior wall. Women with adenomyosis typically experience heavy menstrual bleeding and painful periods that can occur throughout the month. Ultrasound and MRI can detect adenomyosis by showing cysts in the thickened myometrium and an indistinct endomyometrial junction. Treatment depends on a woman's age and fertility desires, ranging from medication like NSAIDs and oral contraceptives to hysterectomy for older, parous women.
An ectopic pregnancy occurs when a fertilized egg implants outside of the uterus, usually in the fallopian tubes. Risk factors include previous ectopic pregnancy, infections, scarring of the fallopian tubes, and fertility treatments. Ectopic pregnancies can cause life-threatening bleeding if not treated properly. Diagnosis involves beta-hCG levels and ultrasound imaging. Treatment options include medication with methotrexate, expectant management with close monitoring, or surgery depending on the stability of the patient and characteristics of the ectopic pregnancy.
A molar pregnancy occurs when abnormal placental tissue develops instead of a fetus. There are two types: complete and partial moles. A complete mole shows trophoblastic proliferation throughout the placenta and no fetal tissue, while a partial mole shows slight, focal proliferation and may contain some fetal tissue. Clinical features can include vaginal bleeding, uterine enlargement beyond dates, and very high hCG levels in the case of a complete mole. Diagnosis is made through histopathological examination of tissue.
1. Thyroid function changes during pregnancy due to increases in thyroid binding globulin, human chorionic gonadotropin, and other factors. This can cause hyperthyroidism or hypothyroidism.
2. Hyperthyroidism occurs in 0.2% of pregnancies, often due to Graves' disease. It increases risk of complications. Hypothyroidism occurs in 2-3% and also increases risks if not treated.
3. Postpartum thyroiditis involves transient hyperthyroidism and/or hypothyroidism after delivery. Long term hypothyroidism can occur. Thyroid cancer diagnosis and treatment requires consideration of pregnancy.
1. Ectopic pregnancy occurs when a fertilized egg implants outside of the uterus, most commonly in one of the fallopian tubes. It has become more common in recent decades due to rising rates of pelvic inflammatory disease, infertility treatments, and intrauterine device use.
2. Ectopic pregnancies are usually diagnosed through clinical history and examination combined with serum human chorionic gonadotropin (hCG) levels and transvaginal ultrasound. hCG levels that are rising slower than normal or an ultrasound that shows an empty uterus with a pregnancy sac located elsewhere can indicate an ectopic pregnancy.
3. Treatment depends on the individual case but typically involves surgery to remove the ectopic pregnancy
- Fibroids are benign smooth muscle tumors that arise from the uterus. They are very common, affecting 20-30% of women.
- Symptoms include heavy menstrual bleeding, pelvic pressure, pain, and infertility. Fibroids can range in size from small to very large masses.
- Diagnosis is usually made through ultrasound imaging. Surgical treatment options include myomectomy to remove fibroids or hysterectomy for multiple or large fibroids. Conservative management is also an option for small asymptomatic fibroids.
gyanaecology.endometriosis and adenomyosis.(dr.salama)student
The document summarizes endometriosis and adenomyosis. Endometriosis occurs when endometrial tissue grows outside the uterus, most commonly on the ovaries, uterine ligaments and pelvis. It causes pain and infertility. Adenomyosis involves endometrial tissue in the uterine wall. Both can be diagnosed by laparoscopy and treated through drugs or surgery, with hysterectomy providing definitive treatment for severe adenomyosis.
The three main categories of early pregnancy disorders are abortion, ectopic pregnancy, and gestational trophoblastic disease. Abortion can be threatened, inevitable, incomplete, complete, or missed depending on whether fetal and placental tissues have been expelled. Ectopic pregnancies occur outside the uterus, often in the fallopian tubes, and can cause pain and bleeding. Gestational trophoblastic disease includes complete and partial hydatidiform moles, as well as choriocarcinoma, and involves abnormal proliferation of trophoblast tissue.
Multiple pregnancies are associated with increased risks for both the mother and fetuses. Maternal risks include preeclampsia, anemia, preterm labor, and postpartum hemorrhage. Fetal risks are also increased and include low birth weight, prematurity, intrauterine growth restriction, congenital anomalies, and twin-twin transfusion syndrome in monochorionic twins. Careful antenatal monitoring and management can help prolong gestation and improve outcomes.
Gestational trophoblastic disease is a heterogeneous group of lesions arising from abnormal placental trophoblast proliferation. It includes premalignant conditions like complete and partial hydatidiform moles, as well as malignant gestational trophoblastic neoplasia (GTN). GTN has varying potential for local invasion and metastasis. While rare, GTN is highly curable even with widespread dissemination. Treatment involves chemotherapy, with single or multi-agent regimens depending on risk factors and disease stage according to the FIGO scoring system. Careful monitoring of beta-hCG levels is important for diagnosis and follow-up.
This document provides information about Caesarean section (C-section), including its definition, indications, types, and procedures. Some key points:
- A C-section is a surgical procedure to deliver babies through incisions in the abdominal and uterine walls after 28 weeks of pregnancy. Its use has steadily increased to around 25% currently due to various medical and safety factors.
- Indications can be maternal, fetal, or both and include conditions like cephalopelvic disproportion, breech presentation, fetal distress, and previous C-section.
- The two main types are lower segment (transverse incision below the bladder) and upper segment (vertical incision through the upper uterus), with
Seminar on gestational trophoblastic disease (gtd) (f inal)Santosh Narayankar
The document discusses gestational trophoblastic disease, specifically hydatidiform mole and choriocarcinoma. It covers the types, causes, risk factors, signs and symptoms, diagnostic methods, treatment options and follow up protocols for these conditions. Hydatidiform mole is characterized by abnormal proliferation of chorionic villi and can be complete or partial. Choriocarcinoma is a highly malignant form that may metastasize and behaves like a carcinoma or sarcoma.
Gestational Trophoblastic Disease By Prof. Dr. Rafia Balochrafiabaloch
This document provides information on gestational trophoblastic disease (GTD), which includes complete and partial hydatidiform moles, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. It discusses the definitions, types, risk factors, pathogenesis, clinical presentation, diagnosis, treatment and management of GTD. Molar pregnancies are diagnosed using ultrasound imaging and quantitative beta-HCG levels. Treatment involves suction dilation and curettage followed by careful monitoring of beta-HCG levels to detect persistent trophoblastic disease. Chemotherapy may be used in high risk cases.
Gestational Trophoblastic Disease (GTD) includes a spectrum of tumors related to abnormal proliferation of trophoblastic cells, including hydatidiform mole (HM), invasive mole (IM), and choriocarcinoma. HM is usually benign but can develop into IM or choriocarcinoma. Diagnosis involves hCG levels, ultrasound, and biopsy. Treatment of HM is surgical evacuation, while IM and choriocarcinoma often require chemotherapy like methotrexate and actinomycin D due to their malignant potential and ability to metastasize. Close monitoring of hCG levels after treatment is important to detect recurrence or persistence of trophoblastic tissue.
Gestational trophoblastic diseases (GTD) represent a spectrum of tumors and tumor-like conditions involving abnormal proliferation of placental tissue. GTD includes hydatidiform mole (complete and partial), invasive mole, choriocarcinoma, and placental site trophoblastic tumor. Complete moles occur when an egg is fertilized by two sperm or a sperm that failed meiosis, resulting in no fetal development. Partial moles have some fetal development but also placental abnormalities. Diagnosis involves ultrasound, beta-HCG levels, and biopsy. Treatment depends on the type but generally involves surgical evacuation and chemotherapy to remove trophoblastic tissue and prevent metastasis.
Gestational trophoblastic disease (GTD) is a spectrum of conditions that includes complete and partial hydatidiform moles, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. Complete molar pregnancies are caused by abnormal fertilization and have no fetal development, while partial moles have some fetal development but also abnormal trophoblast proliferation. Persistent GTD is called gestational trophoblastic neoplasia (GTN) and can be non-metastatic or metastatic. Treatment involves evacuation of the mole and long-term beta-hCG surveillance to monitor for GTN, which is treated with chemotherapy.
Gestational trophoblastic disease (GTD) refers to abnormal cell growth that starts in the placental cells, ranging from benign conditions like molar pregnancies to malignant cancers like choriocarcinoma. GTD is diagnosed through symptoms like vaginal bleeding, enlarged uterus, and high hCG levels and treated with surgery, chemotherapy, or follow-up monitoring depending on whether the condition is benign, low risk, or high risk metastatic cancer. Prognosis is generally good even for metastatic GTD if treated early, though choriocarcinoma can be life-threatening if spread to vital organs occurs.
Uterine tumors can be benign or malignant. Common benign tumors include endometrial polyps which present as exophytic masses in the uterus and are usually asymptomatic. Malignant tumors include endometrial carcinoma and endometrial stromal sarcoma. Endometrial hyperplasia, where the endometrial glands proliferate relative to the stroma, is a risk factor for endometrial carcinoma. Gestational trophoblastic diseases range from complete and partial hydatidiform moles to invasive mole, choriocarcinoma, and placental site trophoblastic tumor. Choriocarcinoma is highly malignant and metastatic while placental site trophoblastic tumor has a more indol
Gestational Trophoblastic Disease (GTD) includes benign and malignant conditions that arise from abnormal trophoblastic cells in the placenta. Types include hydatidiform mole (complete or partial), invasive mole, choriocarcinoma, and placental site trophoblastic tumor. Hydatidiform mole is the most common and can progress to invasive mole or choriocarcinoma in rare cases. Diagnosis is made through beta-hCG levels and ultrasound showing the "snowstorm" appearance. Treatment involves surgical evacuation and chemotherapy depending on risk factors. Follow up monitoring is important to watch for recurrence or progression.
Gestational trophoblastic disease (GTD) includes benign and malignant conditions that arise from abnormal trophoblast cells. The main types are molar pregnancies (complete or partial hydatidiform mole), invasive mole, choriocarcinoma, and placental site trophoblastic tumor. Molar pregnancies are usually cured by suction dilation and curettage, while chemotherapy is used to treat invasive or metastatic malignant GTD. Prognosis is generally good, with cure rates approaching 100% for non-metastatic GTD and 80-90% for high-risk metastatic GTD when treated aggressively with chemotherapy and sometimes surgery.
a PowerPoint presentation of up to date information about gestational trophoblastic diseases , clinical signs and symptoms along with treatment & follow up program
Gestational Trophoblastic Disease -MBChB 6th Year 2018.pptxRobertoMaina2
The document discusses the growth of green energy sources and policies to support their adoption. Many governments around the world have implemented renewable portfolio standards and incentives to increase investment and development of wind, solar, and other renewable resources. These policies have led to significant cost reductions and made green energy more economically viable over the past decade.
Gestational trophoblastic disease refers to a spectrum of conditions that result from abnormal proliferation of trophoblast tissue. This includes complete and partial hydatidiform moles, as well as invasive moles and choriocarcinoma. Complete moles are characterized by marked trophoblastic proliferation and swelling of the chorionic villi, resulting in vesicles within the uterus. The document discusses the incidence, pathology, diagnosis, treatment and follow up of molar pregnancies. Surgical evacuation is usually performed, and long term follow up is needed to monitor for recurrence and the potential development of choriocarcinoma.
This document defines and classifies gestational trophoblastic diseases, which range from benign partial hydatiform moles to highly malignant choriocarcinoma. It describes the characteristics of complete and partial hydatiform moles, persistent trophoblastic disease, invasive moles, and placental site trophoblastic disease. Gestational trophoblastic diseases form a spectrum from very early pregnancies to years after pregnancy, and can include abnormal cell growth that spreads to other organs.
This document discusses gestational trophoblastic disease (GTD), which includes hydatidiform mole, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. It covers the pathologic classifications, risk factors, signs and symptoms, diagnosis, treatment and follow up of GTD. Hydatidiform mole is the most common type and can be complete or partial based on karyotype and histologic features. Invasive mole and choriocarcinoma are malignant forms that can metastasize. Treatment involves suction dilation and curettage for benign moles and chemotherapy for malignant forms. Strict follow up is needed to monitor HCG levels and detect recurrence or progression.
The document summarizes information about early pregnancy disorders, with a focus on molar pregnancies. It describes a case of a 24-year-old woman who is 12 weeks pregnant but experiencing vaginal spotting and passage of vesicles. The most likely diagnosis is a molar pregnancy, as indicated by the enlarged yet doughy uterus and absence of fetal parts. Molar pregnancies can be complete or partial, depending on microscopic features and karyotype. Complete moles have no fetal tissue and usually require suction evacuation and curettage for treatment, with beta-HCG monitoring to watch for persistent trophoblastic disease.
Gestational trophoblastic disease (GTD) includes a spectrum of conditions from benign hydatidiform moles to malignant choriocarcinoma. GTD is classified pathologically and clinically, ranging from benign to malignant trophoblastic disease. Hydatidiform moles are generally benign but have potential to develop into invasive moles or choriocarcinoma. Choriocarcinoma is an aggressive form of GTD that can be life-threatening if not treated properly. Treatment depends on the type and severity of GTD, and may include surgery, single or multi-agent chemotherapy, and radiotherapy, with the goal of curing patients through early diagnosis and appropriate treatment.
Gestational trophoblastic disease (GTD) is a spectrum of conditions resulting from abnormal proliferation of trophoblast cells during pregnancy. GTD includes complete and partial hydatidiform moles, as well as gestational trophoblastic tumors. Complete moles have no fetal development and are caused by paternal genome duplication in an empty egg. Partial moles have some fetal development and a triploid genome. Diagnosis is based on clinical presentation, hCG levels, and ultrasound findings. Treatment is surgical evacuation of the uterus. Patients require follow up of hCG levels to monitor for persistent trophoblastic disease.
Gestational trophoblastic disease (GTD) is a group of rare diseases in which abnormal trophoblast cells grow inside the uterus after conception. In gestational trophoblastic disease (GTD), a tumor develops inside the uterus from tissue that forms after conception (the joining of sperm and egg).
This document defines and classifies gestational trophoblastic disease, which includes hydatidiform mole, invasive mole, and choriocarcinoma. It notes that complete moles have exclusively paternal chromosomes while partial moles are triploid. Suction curettage is usually used to evacuate the uterus for treatment. Patients must be closely monitored with serum hCG tests to check for persistent trophoblastic tissue, which may develop into invasive mole or choriocarcinoma in about 10% of cases. Chemotherapy is used if hCG levels remain elevated or metastases are present.
Similar to Gestational trophoblastic diseases (20)
A Visual Guide to 1 Samuel | A Tale of Two HeartsSteve Thomason
These slides walk through the story of 1 Samuel. Samuel is the last judge of Israel. The people reject God and want a king. Saul is anointed as the first king, but he is not a good king. David, the shepherd boy is anointed and Saul is envious of him. David shows honor while Saul continues to self destruct.
Temple of Asclepius in Thrace. Excavation resultsKrassimira Luka
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
This presentation was provided by Racquel Jemison, Ph.D., Christina MacLaughlin, Ph.D., and Paulomi Majumder. Ph.D., all of the American Chemical Society, for the second session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session Two: 'Expanding Pathways to Publishing Careers,' was held June 13, 2024.
Chapter wise All Notes of First year Basic Civil Engineering.pptxDenish Jangid
Chapter wise All Notes of First year Basic Civil Engineering
Syllabus
Chapter-1
Introduction to objective, scope and outcome the subject
Chapter 2
Introduction: Scope and Specialization of Civil Engineering, Role of civil Engineer in Society, Impact of infrastructural development on economy of country.
Chapter 3
Surveying: Object Principles & Types of Surveying; Site Plans, Plans & Maps; Scales & Unit of different Measurements.
Linear Measurements: Instruments used. Linear Measurement by Tape, Ranging out Survey Lines and overcoming Obstructions; Measurements on sloping ground; Tape corrections, conventional symbols. Angular Measurements: Instruments used; Introduction to Compass Surveying, Bearings and Longitude & Latitude of a Line, Introduction to total station.
Levelling: Instrument used Object of levelling, Methods of levelling in brief, and Contour maps.
Chapter 4
Buildings: Selection of site for Buildings, Layout of Building Plan, Types of buildings, Plinth area, carpet area, floor space index, Introduction to building byelaws, concept of sun light & ventilation. Components of Buildings & their functions, Basic concept of R.C.C., Introduction to types of foundation
Chapter 5
Transportation: Introduction to Transportation Engineering; Traffic and Road Safety: Types and Characteristics of Various Modes of Transportation; Various Road Traffic Signs, Causes of Accidents and Road Safety Measures.
Chapter 6
Environmental Engineering: Environmental Pollution, Environmental Acts and Regulations, Functional Concepts of Ecology, Basics of Species, Biodiversity, Ecosystem, Hydrological Cycle; Chemical Cycles: Carbon, Nitrogen & Phosphorus; Energy Flow in Ecosystems.
Water Pollution: Water Quality standards, Introduction to Treatment & Disposal of Waste Water. Reuse and Saving of Water, Rain Water Harvesting. Solid Waste Management: Classification of Solid Waste, Collection, Transportation and Disposal of Solid. Recycling of Solid Waste: Energy Recovery, Sanitary Landfill, On-Site Sanitation. Air & Noise Pollution: Primary and Secondary air pollutants, Harmful effects of Air Pollution, Control of Air Pollution. . Noise Pollution Harmful Effects of noise pollution, control of noise pollution, Global warming & Climate Change, Ozone depletion, Greenhouse effect
Text Books:
1. Palancharmy, Basic Civil Engineering, McGraw Hill publishers.
2. Satheesh Gopi, Basic Civil Engineering, Pearson Publishers.
3. Ketki Rangwala Dalal, Essentials of Civil Engineering, Charotar Publishing House.
4. BCP, Surveying volume 1
This presentation was provided by Rebecca Benner, Ph.D., of the American Society of Anesthesiologists, for the second session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session Two: 'Expanding Pathways to Publishing Careers,' was held June 13, 2024.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...indexPub
The recent surge in pro-Palestine student activism has prompted significant responses from universities, ranging from negotiations and divestment commitments to increased transparency about investments in companies supporting the war on Gaza. This activism has led to the cessation of student encampments but also highlighted the substantial sacrifices made by students, including academic disruptions and personal risks. The primary drivers of these protests are poor university administration, lack of transparency, and inadequate communication between officials and students. This study examines the profound emotional, psychological, and professional impacts on students engaged in pro-Palestine protests, focusing on Generation Z's (Gen-Z) activism dynamics. This paper explores the significant sacrifices made by these students and even the professors supporting the pro-Palestine movement, with a focus on recent global movements. Through an in-depth analysis of printed and electronic media, the study examines the impacts of these sacrifices on the academic and personal lives of those involved. The paper highlights examples from various universities, demonstrating student activism's long-term and short-term effects, including disciplinary actions, social backlash, and career implications. The researchers also explore the broader implications of student sacrifices. The findings reveal that these sacrifices are driven by a profound commitment to justice and human rights, and are influenced by the increasing availability of information, peer interactions, and personal convictions. The study also discusses the broader implications of this activism, comparing it to historical precedents and assessing its potential to influence policy and public opinion. The emotional and psychological toll on student activists is significant, but their sense of purpose and community support mitigates some of these challenges. However, the researchers call for acknowledging the broader Impact of these sacrifices on the future global movement of FreePalestine.
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.pptHenry Hollis
The History of NZ 1870-1900.
Making of a Nation.
From the NZ Wars to Liberals,
Richard Seddon, George Grey,
Social Laboratory, New Zealand,
Confiscations, Kotahitanga, Kingitanga, Parliament, Suffrage, Repudiation, Economic Change, Agriculture, Gold Mining, Timber, Flax, Sheep, Dairying,
2. Gestational Trophoblastic
Diseases
Gestational trophoblastic disease (GTD)
is a term used for a group of pregnancy-
related tumours. The cells that form
gestational trophoblastic tumours are called
trophoblasts and come from tissue that
grows to form the placenta during
pregnancy.
3. Pathological Classification
The main types of gestational trophoblastic diseases are:
Hydatidiform mole
1.complete mole
2.partial mole
Invasive mole
Choriocarcinoma
Placental-site trophoblastic tumor
5. Hydatidiform Mole
(Molor Pregnancy)
It is made up of villi that have
become swollen with fluid. The
swollen villi grow in clusters that
look like bunches of grapes. This
is called a molar pregnancy, but it
is not possible for a normal baby to
form. Still in rare cases (less than
1 in 100), a normal fetus can
develop alongside the molar
pregnancy. These moles are not
cancerous, but they can develop
into cancerous GTDs.
7. Complete Mole
An abnormal pregnancy which consists of placental
tissue only and there is no embroyo in it.
These mole most often develops when 1 or 2 sperm
cells fertilize an egg cell that contains no nucleus or
DNA (an “empty” egg cell). All the genetic material
comes from the father's sperm cell. Therefore, there is
no fetal tissue.
10. Partial Mole
• In this form the embryo or fetus coexist
with placenta abnormality through it
tends to die at an early cystitis.
• In abnormal parts of placenta the
hyperplasia only involve
synctiotrophoblast.
12. Clinical symptoms:
• Symptoms of early pregnancy:- Patients history of amenorrhea
usually for 4-6 months.
• Vaginal Bleeding:- Patient complains of recurrent vaginal
bleeding something there is history of brownish vaginal discharge.
Bleeding usually starts is 3rd or 4th months of pregnancy.
• Absence of Quickening:- Fetal movements are never felt except
in partial mole.
13. Clinical Signs:
1. Size of uterus:- In most cases the size of uterus is
excessively larger than expected for duration of
amenorrhea.
2. Absence of uterus Contractions:- In molar pregnancy
the uterus feels doughy and does not contract.
3.Bilateral ovarian enlargement:- In 25% cases bilateral
ovarian enlargement palpable.
4.Absence of Foetal Part:- Foetal part not palpable and
feotal heart is absent.
5.Pre eclampcia:- In 50% case signs of preeclampsia
especially in first half of pregnancy.
14. Diagnosis
• Ultrasonography: Snow storm appearance on
ultrasound.
• Beta HCG level:- HCG ideal marker for diagnosis of
gestational trophoblastic disease. Hcg is produced by
synctiotrophoblast cell of placenta. In normal pregnancy
its max amount is produced at 8-10 weeks and after it
falls..
• In molar pregnancy it is produced in very large
amount and its serum and urine level continue to risk
beyond 12 weeks of amenorrhea
15. Treatment:
• The aim of treatment is to remove trophoblastic tissue
from uterus and eliminate it from other body system.
1. Suction Curettage:
Method of choice for evacuation of H mole under 16 weeks
of gestation
16. Invasive Mole:
• Its is a complication of hydatidiform mole but may
rarely develop after partial mole. Invasive mole may
metastasize to any part of body but commonly involves
lungs.
This retains hydropic villi, which penetrate the uterine
wall deeply, possibly causing rupture and sometimes life-
threatening hemorrhage.
17.
18.
19. Choriocarcinoma:
It is rapidly progressive , highly malignant tumor which
originates from chorionic epithelium.
They usually appear as hemorrhagic, necrotic uterine
masses. Sometimes the necrosis is so extensive that little
viable tumor remains.
In contrast with hydatidiform moles and invasive
moles,chorionic villi are not formed;instead, the tumor is
composed of anaplastic cuboidal cytotrophoblasts and
syncytiotrophoblasts
21. Placental Site Trophoblastic Tumor
Placental site trophoblastic tumor is a form of gestational
trophoblastic disease, which is thought to arise from intermediate
trophoblast.It may secrete human placental lactogen ,and result in a
false-positive pregnancy test.
These uncommon diploid tumors, often have XX in karyotype,
typically arise a few months after pregnancy
22.
23. Clinical features :
• Vaginal bleeding: intermittent
vaginal bleeding
• Vaginal discharge: brownish
vaginal discharge
Other weakness:
• Cough
• Neurological symptoms
• Abdominal or vaginal mass
• Amenorrhea